Open House Discount Agreements for Minoxidil
Original notice title
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Minoxidil, ATC C02DC01
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
30 / 100
Risk factors
If a competitive discount agreement for Minoxidil (awarded via open procedure) comes into effect, the open-house contra...
The buyer is not obliged to purchase any volumes; the contract only sets discount terms.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Strong opportunityKey Facts
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Feb 2028
- Non-exclusive pharmaceutical discount agreements for Minoxidil (ATC C02DC01) with AOK Bayern health insurance fund
- Contracts are open to all qualified pharmaceutical companies
Show full summary
Open-house model for non-exclusive discount agreements on Minoxidil (ATC C02DC01) with AOK Bayern. All qualified pharmaceutical companies can join at any time during the contract period (March 2026 – February 2028) by submitting required documents. No competitive selection; contracts automatically terminate if a competitive discount agreement for the same active ingredient comes into effect.
Risks
If a competitive discount agreement for Minoxidil (awarded via open procedure) comes into effect, the open-house contra...
The buyer is not obliged to purchase any volumes; the contract only sets discount terms.
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be a pharmaceutical company
- Signed contract and annex 'Festlegung der vertragsgegenständlichen Arzneimittel' required
Administrative
- Signed declaration of reliability required
Requirements may be incomplete.
Buyer
Location
München, DEU
Website
Buyer profile
Identifier
DE811695320
Activity
Health
Lots (1)
LOT-0001
Open House Discount Agreements for Minoxidil
Non-exclusive framework agreement for discount on Minoxidil pharmaceutical products. Contracts run from earliest 01.03.2026 to 29.02.2028. Entry possible until 03.01.2028. Rolling monthly submission deadlines.
Location
Duration
Category
Deadline
Award details
Siehe kurze Beschreibung ACHTUNG: Die Vertragsunterlagen sind zwingend über den Kommunikationsbereich im Vergabeportal www.dtvp.de einzureichen und keinesfalls über den Angebotsbereich! BITTE BEACHTEN SIE: Die FRIST für einen Vertragsschluss zum nächsten Monatsersten endet jeweils am DRITTEN des Vormonats.
Value note
Show original TED data
Original lot title
Open house Arzneimittelrabattverträge Minoxidil, ATC C02DC01
Original TED description
Siehe kurze Beschreibung ACHTUNG: Die Vertragsunterlagen sind zwingend über den Kommunikationsbereich im Vergabeportal www.dtvp.de einzureichen und keinesfalls über den Angebotsbereich! BITTE BEACHTEN SIE: Die FRIST für einen Vertragsschluss zum nächsten Monatsersten endet jeweils am DRITTEN des Vormonats.
Procurement Details
- Publication date
- 13 Jan 2026
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 25457-2026
Documents (2)
Similar tenders
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
30 / 100
Risk factors
If a competitive discount agreement for Minoxidil (awarded via open procedure) comes into effect, the open-house contra...
The buyer is not obliged to purchase any volumes; the contract only sets discount terms.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications